VERTEX PHARMACEUTICALS INC (VRTX) Stock News
NASDAQ:VRTX - Nasdaq - US92532F1003 - Common Stock - Currency: USD
VRTX Latest News, Press Relases and Analysis
Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now
Now may be a smart time to buy small stakes in these fundamentally robust companies.
Earnings To Watch: Vertex Pharmaceuticals (VRTX) Reports Q1 Results Tomorrow
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.
Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know
Vertex Pharmaceuticals (VRTX) reachead $509.47 at the closing of the latest trading day, reflecting a +1.19% change compared to its last close.
Jim Cramer Says Buy Citigroup (C): “Not My Favorite, But I Like Your Idea”
We recently published a list of Jim Cramer Recently Discussed These 9 Stocks. In this article, we are going to take a look at where Citigroup Inc. (NYSE:C) stands against other stocks that Jim Cramer discussed recently. Jim Cramer, the host of Mad Money, discussed the current economic outlook on Monday as he outlined why […]
What Analyst Projections for Key Metrics Reveal About Vertex (VRTX) Q1 Earnings
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Vertex (VRTX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.
Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for
Entrada Therapeutics (TRDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: TRDA
Suze Orman: Why a Roth 401(k) Is the Best Investing Move for Your Retirement
The stock market has taken some major dips recently, which has made some investors worried when it comes to their retirement accounts. Some people might be looking into alternative strategies to keep...
Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: TVTX
Analysis-After 100 days under Trump, investors reassess the allure of 'brand USA'
NEW YORK (Reuters) -A bruising rollercoaster ride for markets in the first 100 days of the Trump administration has seen some investors move away from American assets, but it remains to be seen whether policies have caused a sustained shift away from the United States. "The question of whether this has caused irreversible damage to the U.S. markets and economic system is the existential one, but we don’t yet have a long-term answer," said Liz Ann Sonders, chief investment strategist, Charles Schwab & Co. "We know that it’s done a tremendous amount of damage and that our partners are questioning whether we’re reliable when it comes to trade or other things." April 30 will mark the 100th day of Trump's presidency.
Investors fear Big Oil could cut share buybacks as crude prices slump
HOUSTON (Reuters) -When Exxon Mobil and Chevron report first-quarter results this week, investors will be focused on how falling oil prices have increased the risk to dividends and share repurchases for the rest of 2025. Big Oil has made returning cash to investors through dividends and share repurchases a strategic cornerstone of its efforts to woo Wall Street. U.S. President Donald Trump's global tariff announcements have stoked fears of a recession and weaker oil demand, prompting forecasters to lower their oil price outlooks.
My 5 Top Stocks to Buy Right Now in This Highly Volatile Market
The major market indexes are behaving like a frantic yo-yo, swinging up or down depending on the latest tariff- or Fed-related news from the White House. You can still find attractive stocks despite all of the turbulence. Here are my five top stocks to buy right now in this highly volatile market.
Stock Market Sell-Off: 1 Magnificent Dividend Stock to Buy Right Now
Dividends are a great way to build sustainable income over the long term, especially if you buy dividend growth stocks. Stock market volatility is a great reminder that a portfolio dedicated to hypergrowth technology stocks that do not pay dividends can lead to huge ups and downs in the short run. In order to minimize this roller coaster -- if that is your goal -- you might want to add some dividend stocks to your portfolio.
1 Stock to Buy, 1 Stock to Sell This Week: Meta Platforms, Pfizer
• Tariff headlines, ‘Mag 7’ earnings, U.S. jobs report, and PCE inflation data will be in focus this week.
Is The Greenbrier Companies, Inc. (GBX) Among The Best Railroad Stocks To Buy According To Billionaires?
We recently published a list of 10 Best Railroad Stocks To Buy According To Billionaires. In this article, we are going to take a look at where The Greenbrier Companies, Inc. (NYSE:GBX) stands against other best railroad metals stocks to buy according to billionaires. The trade war initiated by President Trump will force freight railroads […]
3 Dividend ETFs to Buy With $2,000 and Hold Forever
They're all compelling on their own, but together, they're a formidable income-driving trio.
Now Streaming: Analysts boost Netflix targets after Q1 beat
“Now Streaming” is The Fly’s weekly recap of the stories surrounding the biggest content streamers. PLAYING THIS WEEKEND: Among this weekend’s highly-anticipated new streaming content is the first few episodes of “Andor,” a drama series set in the “Star Wars” universe, on Disney+ (DIS). Meanwhile, Netflix (NFLX) subscribers can catch the fifth season of drama series “You,” as well as neo-noir action thriller film “Havoc,” starring Tom Hardy and Forest Whitaker. Additionally, Amazon Prime Video (
Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts
Vertex Pharmaceuticals (VRTX) closed at $492.47 in the latest trading session, marking a +0.01% move from the prior day.
Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds
The biopharmaceutical industry is positioned for continued recovery, driven by recent FDA approvals and billion-dollar strategic collaborations.
Mentions: GILD
Tariff turmoil: What P&G, Pepsi and other companies are saying about tariffs
Tariff worries continue hanging over companies as they report their latest financial results and try to provide guidance on their path ahead. The tariff and trade picture continues shifting and that makes it difficult for companies and investors to make a reliable assessment of any impact to costs and sales. Seemingly few industries or companies are being spared from the uncertainty.
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is CommScope Holding Company, Inc. (COMM) the Best Multibagger Penny Stock to Buy According to Billionaires?
We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are going to take a look at where CommScope Holding Company, Inc. (NASDAQ:COMM) stands against other best multibagger penny stocks to buy according to billionaires. Penny stocks always seem like bargains for gaining exposure to […]
Is Lumen Technologies, Inc. (LUMN) the Best Multibagger Penny Stock to Buy According to Billionaires?
We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Lumen Technologies, Inc. (NYSE:LUMN) stands against other best multibagger penny stocks to buy according to billionaires. Penny stocks always seem like bargains for gaining exposure to some […]
Jim Cramer on CVS Health (CVS): “CVS Is the Best… the Last One Standing”
We recently published a list of Jim Cramer Reveals Where Investors Fled During Tariff Selloff & Discusses 10 Stocks. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer […]
GraniteShares Launches New Leveraged, Single-Stock EV ETFs
- GraniteShares just introduced two leveraged single-stock ETFs. - The new ETFs are focused on EV-makers Lucid Group and Rivian Automotive. - The expense ratio is 1.15% for both funds.
Jim Cramer on Shopify (SHOP): “De Minimis Will Sort Itself Out”
We recently published a list of Jim Cramer Reveals Where Investors Fled During Tariff Selloff & Discusses 10 Stocks. In this article, we are going to take a look at where Shopify Inc. (NASDAQ:SHOP) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer discussed […]
Jim Cramer on CSX Corp (CSX): “There Is an Element of Forgiveness Today”
We recently published a list of Jim Cramer Reveals Where Investors Fled During Tariff Selloff & Discusses 10 Stocks. In this article, we are going to take a look at where CSX Corporation (NASDAQ:CSX) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer discussed […]
Plug Power Inc. (PLUG): Among EV Penny Stock From $10 to Under $1
We recently published a list of EV Penny Stocks List: From $10 to Under $1. In this article, we are going to take a look at where Plug Power Inc. (NASDAQ:PLUG) stands against other stocks in EV penny list: from $10 to under $1. The global electric vehicle (EV) market is on a roll despite […]
NVIDIA Corporation (NVDA): Among Stocks That Could 10X Over the Next 2 Years
We recently published a list of 9 Stocks That Could 10X Over the Next 2 Years. In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands against other stocks that could 10X over the next 2 years. US Tariffs and the Stock Market Turmoil While tariffs from the US […]